(39) reported that circulating ANGPTL8 levels increased by 52% and 48% in patients with moderate-to-severe NAFLD compared to those without or with mild NAFLD, respectively. Here, ANGPTL8 is linked to metabolic dysfunction-associated steatotic liver disease.